PSY2 Impact of Mepolizumab on Health-Related Quality of Life in Patients With Hypereosinophilic Syndrome
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.1143
https://www.valueinhealthjournal.com/article/S1098-3015(21)01360-7/fulltext
Title :
PSY2 Impact of Mepolizumab on Health-Related Quality of Life in Patients With Hypereosinophilic Syndrome
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01360-7&doi=10.1016/j.jval.2021.04.1143
First page :
Section Title :
Open access? :
No
Section Order :
10637